Formulatrix, Inc. v. Rigaku Automation, Inc.

CourtDistrict Court, D. Massachusetts
DecidedNovember 1, 2018
Docket1:15-cv-12725
StatusUnknown

This text of Formulatrix, Inc. v. Rigaku Automation, Inc. (Formulatrix, Inc. v. Rigaku Automation, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Massachusetts primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Formulatrix, Inc. v. Rigaku Automation, Inc., (D. Mass. 2018).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS

FORMULATRIX, INC., ) ) Plaintiff, ) v. ) CIVIL ACTION ) NO. 15-12725-JGD RIGAKU AUTOMATION, INC. and ) RIGAKU AMERICAS HOLDING, INC., ) ) Defendants. )

MEMORANDUM OF DECISION AND ORDER ON CROSS-MOTIONS FOR SUMMARY JUDGMENT

November 1, 2018 DEIN, U.S.M.J. I. INTRODUCTION

Plaintiff Formulatrix, Inc. (“Formulatrix”) has brought this action against Rigaku Automation, Inc. (“Rigaku”) and Rigaku Americas Holding, Inc. (“Rigaku Americas”) (together “Rigaku”) for breach of contract and other causes of action related to a January 2015 Customer Support Agreement (“CSA”) between the parties. At the heart of Plaintiff’s complaint is its allegation that Rigaku failed to comply with certain provisions of the CSA governing the transmission of business documents within a 90 day period. Defendants dispute this allegation and assert counterclaims against Plaintiff, alleging that Formulatrix breached the CSA by improperly withholding installment payments due to Rigaku and that Formulatrix violated Mass. Gen. Laws ch. 93A by engaging in a pattern of extra-contractual demands coupled with the threat of contractual nonperformance or litigation. On June 22, 2015, Formulatrix initiated the instant action against Defendants alleging the following causes of action: breach of contract; tortious interference with contractual and/or advantageous business relationship; breach of the covenant of good faith and fair dealing;

request for attorneys’ fees under the CSA; unfair and deceptive conduct in violation of Mass. Gen. Laws ch. 93A § 11; and enforcement of a guaranty given by Rigaku America in the CSA. (See Docket No. 1). On April 5, 2016, Defendants filed a Counterclaim asserting claims of breach of contract; breach of the covenant of good faith and fair dealing; declaratory judgment; violation of Mass. Gen. Laws ch. 93A § 11; and attorneys’ fees under the CSA. (See Docket No. 17). On August 25, 2016, following a ruling on Defendants’ motion to dismiss, which struck

Formulatrix’s tortious interference and ch. 93A claims (Docket No. 15), Formulatrix filed an Amended Complaint reasserting the claims that survived Defendants’ motion to dismiss. (See Docket No. 42). On September 1, 2016, Defendants filed a Counterclaim reasserting the same causes of action asserted in its original Counterclaim. (See Docket No. 43). This matter is before the court on Formulatrix’s “Motion for Partial Summary Judgment”

(Docket No. 66), by which Formulatrix is seeking summary judgment with respect to Rigaku’s claims for (1) breach of contract, (2) breach of the covenant of good faith and fair dealing, and (3) violation of Mass. Gen. Laws ch. 93A. This matter is also before the court on Rigaku’s “Motion for Partial Summary Judgment” (Docket No. 70), by which Rigaku is seeking summary judgment with respect to all of Formulatrix’s remaining claims, and affirmatively on its own breach of contract and breach of the covenant of good faith and fair dealing claims. Both

parties are also seeking summary judgment on the issue of entitlement to attorneys’ fees. For the reasons detailed herein, Formulatrix’s Motion for Partial Summary Judgment is DENIED and Rigaku’s Motion for Partial Summary Judgment is ALLOWED IN PART AND DENIED IN PART. Specifically, Rigaku’s motion is ALLOWED with respect to Count I of Rigaku’s Counterclaim (breach of contract), Count II of Formulatrix’s Amended Complaint (breach of covenant of good

faith and fair dealing), but DENIED with respect to Count IV of Formulatrix’s Amended Complaint (guaranty) and Count V of Rigaku’s Counterclaim (attorneys’ fees). With respect to Count I of Formulatrix’s Amended Complaint (breach of contract), Rigaku’s motion is ALLOWED as to the reports required by Art. 2.02 and accurate representations and warranties under Schedule 5.06, but otherwise DENIED. As detailed herein, this court concludes that the issue of entitlement to attorneys’ fees is premature.

II. STATEMENT OF FACTS1 The following facts are undisputed unless otherwise indicated. The CSA Formulatrix is in the business of developing, manufacturing, and selling protein crystallization automation products (“Automation Products”) to customers in the protein

1 Unless otherwise indicated, the facts are derived from Formulatrix’s Statement of Material Facts in Support of its Motion for Partial Summary Judgment (Docket No. 68) (“PF __”); the Affidavit of Counsel in Support of Formulatrix’s Motion for Partial Summary Judgment (Docket No. 69) and the exhibits attached thereto (“PEx. __”); Rigaku’s Response to Formulatrix’s Statement of Material Facts (Docket No. 81) (“DR __”) and Rigaku’s Additional Statement of Material Facts (Docket No. 81) (“DOppF __”); Rigaku’s Appendix of Materials Supporting its Opposition to Formulatrix’s Motion for Partial Summary Judgment (Docket No. 82) and the exhibits attached thereto (“DOppEx. __); Formulatrix’s Responses to Rigaku’s Additional Statement of Material Facts (Docket No. 85) (“PROppF __”); Formulatrix’s Affidavit of Counsel in Support of its Reply Brief (Docket No. 86) and the exhibits attached thereto (“PReply Ex. __”); Rigaku’s Statement of Undisputed Material Facts in Support of its Motion for Partial Summary Judgment (Docket No. 72) (“DF __”); Rigaku’s Appendix of Materials Supporting its Motion for Partial Summary Judgment (Docket No. 73) (“DEx. __”); Formulatrix’s Responses to Rigaku’s Statement of Material Facts (Docket No. 78) (“PR __”); Formulatrix’s Affidavit of Counsel in Support of its Opposition to Rigaku’s Motion for Partial Summary Judgment (Docket No. 79) and the exhibits attached thereto (“POppEx. __”); and Rigaku’s Appendix of Materials Supporting its Reply Brief (Docket No. 88) (“DReplyEx. __”). crystallization industry. (PF ¶ 1). As of the beginning of 2015, Rigaku was a direct competitor to Formulatrix in the Automation Products industry. (PF ¶¶ 2, 4). On January 15, 2015, Formulatrix presented Rigaku with an offer to purchase its assets, and thereafter, the two

companies engaged in negotiations related to the offer. (DOppF ¶ 1). Effective January 20, 2015, Formulatrix and Rigaku entered into a Customer Support Agreement (“CSA” or “Agreement”). (PF ¶ 2). Generally speaking, under the CSA, Rigaku agreed to exit the business of developing, manufacturing, and selling protein-crystallization- automation equipment; to transfer certain assets and license certain intellectual property to Formulatrix; to transfer certain business documents to Formulatrix within 90 days; and to

provide transition support services to Formulatrix for up to 90 days. (See PEx. 1 Arts. 1.01, 1.02, 2.01, 2.04, 3.01). In turn, Formulatrix agreed to provide support services to Rigaku’s protein- crystallization customers and to pay Rigaku $2 million upon the execution of the CSA and then an additional sum of $1.825 million in equal installments over the course of 12 months commencing on January 20, 2016, one year after the execution of the CSA. (See PEx. 1 Arts.

1.02, 4.01). The parties agree that Formulatrix did not conduct due diligence with respect to Rigaku’s financial representations and warranties before signing the CSA. (PF ¶ 6; DR ¶ 6). However, the parties dispute whether this was by mutual agreement, as Rigaku contends, or because Rigaku refused to allow Formulatrix to conduct such due diligence, as Formulatrix contends. (See DR ¶ 6; PROppF ¶ 2). Among the representations and warranties provided by

Rigaku in the CSA is a schedule containing Rigaku’s financial information. (PEx. 1 Art. 5.06, Schedule 5.06).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Hewitt v. Helms
482 U.S. 755 (Supreme Court, 1987)
Farrar v. Hobby
506 U.S. 103 (Supreme Court, 1992)
Arthur D. Little, Inc. v. Dooyang Corp.
147 F.3d 47 (First Circuit, 1998)
Jasty v. Wright Medical Technology, Inc.
528 F.3d 28 (First Circuit, 2008)
Milissa Garside v. Osco Drug, Inc.
895 F.2d 46 (First Circuit, 1990)
Samuel Mesnick v. General Electric Company
950 F.2d 816 (First Circuit, 1991)
Fairfield 274-278 Clarendon Trust v. Robert M. Dwek
970 F.2d 990 (First Circuit, 1992)
Young v. Wells Fargo Bank, N.A.
717 F.3d 224 (First Circuit, 2013)
Vineberg v. Bissonnette
548 F.3d 50 (First Circuit, 2008)
Dan Barclay, Inc. v. Stewart & Stevenson Services, Inc.
761 F. Supp. 194 (D. Massachusetts, 1991)
Ward v. American Mutual Liability Insurance
443 N.E.2d 1342 (Massachusetts Appeals Court, 1983)
Hawthorne's, Inc. v. Warrenton Realty, Inc.
606 N.E.2d 908 (Massachusetts Supreme Judicial Court, 1993)
Bird v. Bird
509 N.E.2d 289 (Massachusetts Appeals Court, 1987)

Cite This Page — Counsel Stack

Bluebook (online)
Formulatrix, Inc. v. Rigaku Automation, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/formulatrix-inc-v-rigaku-automation-inc-mad-2018.